Güner Söyletir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Güner Söyletir has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
- Gülşen Altınkanat Gelmez
Marmara University School of Medicine, Department of Medical Microbiology, Istanbul, Turkey
8 shared publications - Nurver Ulger Toprak
Marmara University, School of Medicine
8 shared publications - Ayşe Karaaslan
Department of Pediatric Infectious Diseases, University of Health Sciences, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul, Turkey
5 shared publications - Ufuk Hasdemir
Marmara University School of Medicine, Department of Medical Microbiology, Istanbul, Turkey
5 shared publications - Volkan Korten
Marmara University, School of Medicine
5 shared publications - Eda Kepenekli
Faculty of Medicine, Department of Pediatrics, Division of Pediatric Infectious Diseases, Marmara University, Istanbul, Turkey
4 shared publications
Latest Publications
- 22 April 2026
- Published by Academician Publishing
- p. 45-51
Grup 2a β-laktamazlar
Grup 2a β-laktamazlar, Ambler sınıflamasında A sınıfında yer alan ve dar spektrumlu penisilinazları kapsayan enzimlerdir. Temel temsilcisi PC1 olup özellikle benzilpenisilin ve türevlerini hidrolize ederken sefalosporinlere, karbapenemlere ve monobaktamlara düşük düzeyde etkilidir. Penisilinin 1940’larda klinik kullanıma girmesinden kısa süre sonra stafilokoklarda hızla penisilin direnci gelişmiş ve bu direnç penisilinaz üretimine bağlanmıştır. 2000’li yıllara gelindiğinde farklı coğrafyalardan toplanan metisiline duyarlı Staphylococcus aureus (MSSA) izolatlarının %80’den fazlasında blaZ penisilinaz geni bulunmuştur. S. aureus’ta penisilin direncinin iki ana mekanizması vardır: blaZ geni aracılığıyla penisilinaz üretimi ve mecA aracılığıyla PBP2a sentezi. blaZ geninin A–D tipleri tanımlanmıştır; bunlardan özellikle tip A ve C klinik açıdan önemlidir. Bu enzimler sefazolin tedavisinde “inokülum etkisi” (CzIE) ile ilişkilendirilmiş olup tedavi başarısızlıklarına yol açabilmektedir. Latin Amerika’da yapılan geniş bir çalışmada tip C ilk (%37), tip A ise ikinci sırada bulunmuş, CzIE prevalansı %40 olarak bildirilmiştir. Rutin laboratuvarlarda penisilinaz varlığı fenotipik yöntemlerle (disk difüzyon, zon kenarı, nitrosefin testi) araştırılmakta, ancak özellikle alt tip ayrımı yapılamadığı için CzIE’yi öngörmede yetersiz kalmaktadır. Son yıllarda disk difüzyon temelli yeni testler geliştirilmiş olsa da daha geniş ölçekli çalışmalara gereksinim vardır. Sonuç olarak, MSSA enfeksiyonlarında gerek yan etki gerekse ulaşılabilir olması nedeniyle birincil seçenek olarak önerilen sefazolin kullanımında CzIE’nin klinik önemini netleştirmek için ileri araştırmalara gereksinim vardır. Group 2a β-lactamases belong to Ambler class A and include narrow-spectrum penicillinases. Their main representative, PC1, hydrolyzes benzylpenicillin and derivatives, while showing limited activity against cephalosporins, carbapenems, and monobactams. Soon after penicillin entered clinical use in the 1940s, resistance rapidly emerged in staphylococci, mainly due to penicillinase production. By the 2000s, more than 80% of methicillin-susceptible Staphylococcus aureus (MSSA) isolates worldwide carried the blaZ penicillinase gene. Two major resistance mechanisms exist in S. aureus: production of penicillinase encoded by blaZ, and altered penicillin-binding protein PBP2a encoded by mecA. At least four types (A–D) of blaZ have been identified; types A and C are most clinically relevant. These enzymes are linked to the “cefazolin inoculum effect” (CzIE), which may lead to treatment failures. A large Latin American study found type C most prevalent (37%), followed by type A, with an overall CzIE prevalence of 40%. Detection of penicillinase in routine labs relies on phenotypic methods such as disk diffusion, zone edge test, and nitrocefin assay. However, these approaches cannot determine blaZ subtypes and thus are insufficient to predict CzIE. Recently, disk diffusion–based assays have been developed to identify strains associated with inoculum effect, but validation with larger datasets is still required. In conclusion, although cefazolin remains a recommended first-line agent against MSSA infections due to its safety and accessibility, CzIE raises concerns about treatment reliability. Further clinical and laboratory studies are essential to clarify its true impact.
- 22 April 2026
- Published by Academician Publishing
- p. 45-51
Grup 2a β-laktamazlar
Grup 2a β-laktamazlar, Ambler sınıflamasında A sınıfında yer alan ve dar spektrumlu penisilinazları kapsayan enzimlerdir. Temel temsilcisi PC1 olup özellikle benzilpenisilin ve türevlerini hidrolize ederken sefalosporinlere, karbapenemlere ve monobaktamlara düşük düzeyde etkilidir. Penisilinin 1940’larda klinik kullanıma girmesinden kısa süre sonra stafilokoklarda hızla penisilin direnci gelişmiş ve bu direnç penisilinaz üretimine bağlanmıştır. 2000’li yıllara gelindiğinde farklı coğrafyalardan toplanan metisiline duyarlı Staphylococcus aureus (MSSA) izolatlarının %80’den fazlasında blaZ penisilinaz geni bulunmuştur. S. aureus’ta penisilin direncinin iki ana mekanizması vardır: blaZ geni aracılığıyla penisilinaz üretimi ve mecA aracılığıyla PBP2a sentezi. blaZ geninin A–D tipleri tanımlanmıştır; bunlardan özellikle tip A ve C klinik açıdan önemlidir. Bu enzimler sefazolin tedavisinde “inokülum etkisi” (CzIE) ile ilişkilendirilmiş olup tedavi başarısızlıklarına yol açabilmektedir. Latin Amerika’da yapılan geniş bir çalışmada tip C ilk (%37), tip A ise ikinci sırada bulunmuş, CzIE prevalansı %40 olarak bildirilmiştir. Rutin laboratuvarlarda penisilinaz varlığı fenotipik yöntemlerle (disk difüzyon, zon kenarı, nitrosefin testi) araştırılmakta, ancak özellikle alt tip ayrımı yapılamadığı için CzIE’yi öngörmede yetersiz kalmaktadır. Son yıllarda disk difüzyon temelli yeni testler geliştirilmiş olsa da daha geniş ölçekli çalışmalara gereksinim vardır. Sonuç olarak, MSSA enfeksiyonlarında gerek yan etki gerekse ulaşılabilir olması nedeniyle birincil seçenek olarak önerilen sefazolin kullanımında CzIE’nin klinik önemini netleştirmek için ileri araştırmalara gereksinim vardır. Group 2a β-lactamases belong to Ambler class A and include narrow-spectrum penicillinases. Their main representative, PC1, hydrolyzes benzylpenicillin and derivatives, while showing limited activity against cephalosporins, carbapenems, and monobactams. Soon after penicillin entered clinical use in the 1940s, resistance rapidly emerged in staphylococci, mainly due to penicillinase production. By the 2000s, more than 80% of methicillin-susceptible Staphylococcus aureus (MSSA) isolates worldwide carried the blaZ penicillinase gene. Two major resistance mechanisms exist in S. aureus: production of penicillinase encoded by blaZ, and altered penicillin-binding protein PBP2a encoded by mecA. At least four types (A–D) of blaZ have been identified; types A and C are most clinically relevant. These enzymes are linked to the “cefazolin inoculum effect” (CzIE), which may lead to treatment failures. A large Latin American study found type C most prevalent (37%), followed by type A, with an overall CzIE prevalence of 40%. Detection of penicillinase in routine labs relies on phenotypic methods such as disk diffusion, zone edge test, and nitrocefin assay. However, these approaches cannot determine blaZ subtypes and thus are insufficient to predict CzIE. Recently, disk diffusion–based assays have been developed to identify strains associated with inoculum effect, but validation with larger datasets is still required. In conclusion, although cefazolin remains a recommended first-line agent against MSSA infections due to its safety and accessibility, CzIE raises concerns about treatment reliability. Further clinical and laboratory studies are essential to clarify its true impact.
- Open Access
- 22 April 2026
- Published by Academician Publishing
β-Laktam Antibiyotiklere Direnç Güncel Bilgiler Işığında β-Laktamazlar
- 22 April 2026
- Published by Academician Publishing
Open Accessβ-Laktam Antibiyotiklere Direnç Güncel Bilgiler Işığında β-Laktamazlar
- 2 September 2025
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 37 (1) , 55-67
Sexual behaviours and sexually transmitted infections among MSM living with HIV followed at a university hospital in Istanbul, Turkey
Background: Men sex with men (MSM) are accepted as a hidden key population in the dissemination of HIV in Turkey. Understanding sexual behaviours and Sexually Transmitted Infections (STI) frequency in MSM living with HIV is important to provide appropriate health and control policies. Methods: Sexual anamnesis including 5Ps were taken with triple-site (urine, pharyngeal and rectal swab) screening tests, which were performed according to the recommendations in the HIV follow up guidelines, from 45 MSM living with HIV, who were followed and consecutively attended to their control visit Marmara University Pendik Education and Training Hospital, in Istanbul, in 2018. Results: 24.4 % and 26.7 % of participants tested positive for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), respectively. This ratio decreased to 6.7% if urine was the only sample taken to be tested. Syphilis seropositivity increased from 18% to 34% during the HIV diagnosis to triple testing time, which is a median period of 28 months. Conclusion: The data obtained emphasizes the screening and reimbursement of triple testing in key population groups.
- 2 September 2025
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 37 (1) , 55-67
Sexual behaviours and sexually transmitted infections among MSM living with HIV followed at a university hospital in Istanbul, Turkey
Background: Men sex with men (MSM) are accepted as a hidden key population in the dissemination of HIV in Turkey. Understanding sexual behaviours and Sexually Transmitted Infections (STI) frequency in MSM living with HIV is important to provide appropriate health and control policies. Methods: Sexual anamnesis including 5Ps were taken with triple-site (urine, pharyngeal and rectal swab) screening tests, which were performed according to the recommendations in the HIV follow up guidelines, from 45 MSM living with HIV, who were followed and consecutively attended to their control visit Marmara University Pendik Education and Training Hospital, in Istanbul, in 2018. Results: 24.4 % and 26.7 % of participants tested positive for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), respectively. This ratio decreased to 6.7% if urine was the only sample taken to be tested. Syphilis seropositivity increased from 18% to 34% during the HIV diagnosis to triple testing time, which is a median period of 28 months. Conclusion: The data obtained emphasizes the screening and reimbursement of triple testing in key population groups.
- 23 October 2023
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 57 (4) , 507-534
The Change in Antimicrobial Resistance During the COVID-19 Pandemic in Türkiye
Antimicrobial resistance (AMR) is one of the most important problems threatening human health worldwide. The impact of the Coronavirus disease-2019 (COVID-19) pandemic on AMR continues to be discussed. Some researchers argue that the pandemic will increase AMR rates, while others suggest the opposite. The aim of this study was to investigate the change in AMR of Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus strains in three cross-sectional periods in Turkiye, the first one before the COVID-19 pandemic, the second and the third one during the pandemic. The change in antibiotic susceptibility in Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus strains isolated from urine, blood, and lower respiratory tract samples of patients hospitalized in intensive care units and wards of hospitals before (November 2019) and during the COVID-19 pandemic (November 2020 and July 2021) was investigated in this study. A total of 17 voluntary hospitals, members of the Antibiotic Sus- ceptibility Surveillance Study Group (ADSI) of the Society for Clinical Microbiology Specialists (KLIMUD), participated in the study. Identification of bacteria was performed with automated bacterial identification systems (VITEK2, bioMerieux, France or Phoenix, BD, USA). Antibiotic susceptibility tests were performed in one center with the Kirby-Bauer disc diffusion method and in other centers with automated antibi- otic susceptibility test systems (VITEK2, bioMerieux, France or Phoenix, BD, USA), and the results were evaluated according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. Antibiotic susceptibility ratios were statistically analyzed using either the chi-square or Fisher's exact test. A p-value of < 0.05 was considered statistically significant. Antibiotic susceptibility test results of a total of 4030 strains; 1152, 1139, and 1739 belonging to November 2019, November 2020, and July 2021, respectively; were examined. While cefotaxime and ceftazidime susceptibility rates in E.coli strains increased during the pandemic period compared to previous period (p= 0.04, p= 0.001, respectively); nitrofurantoin sensitivity (p= 0.02) and extended-spectrum beta-lactamase (ESBL) ratios (p< 0.001) were found to be decreased. It was determined that the susceptibility rates of all other examined antimicrobials did not change statistically. It was observed that the susceptibility rates of all antibiotics in K.pneumoniae isolates decreased during the pandemic period, but the ESBL rates increased between 2019-2020 (p= 0.01) and decreased between 2020-2021 (p= 0.02). It was found that ESBL rates increased before and after the pandemic. It was observed that the susceptibility to ciprofloxacin (p= 0.0001), levofloxacin (p= 0.003), and gentamicin (p= 0.005) in S.aureus strains increased during the pandemic period. No significant changes were observed in other antibiotic susceptibility rates. Methicillin resistance of S.aureus (MRSA) strains decreased between 2019-2020 (p= 0.03) and increased again in 2021 (p= 0.04) and returned to the pre-pandemic rate. Our study results suggest that the measures taken to reduce the spread of COVID-19 with the pandemic (such as quarantine practices, increased hand hygiene, mask use, and national/international travel restriction) may reduce the spread of bacteria such as ESBL-producing E.coli and the rate of MRSA, which is considered as a hand hygiene indicator. The increase in the later stages of the pandemic recalls the relaxation in compliance with hand hygiene rules. The decrease in the susceptibility rate of K.pneumoniae isolates to antibiotics and the increase in the ESBL rate may be due to inappropriate and excessive use of antibiotics during the pandemic period. However, we believe that these data should be supported by studies to be conducted nowadays when all the rules and measures are back as if the pandemic has ended.
- 23 October 2023
- Published by Bilimsel Tip Publishing House in Mikrobiyoloji Bulteni
- Vol. 57 (4) , 507-534
The Change in Antimicrobial Resistance During the COVID-19 Pandemic in Türkiye
Antimicrobial resistance (AMR) is one of the most important problems threatening human health worldwide. The impact of the Coronavirus disease-2019 (COVID-19) pandemic on AMR continues to be discussed. Some researchers argue that the pandemic will increase AMR rates, while others suggest the opposite. The aim of this study was to investigate the change in AMR of Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus strains in three cross-sectional periods in Turkiye, the first one before the COVID-19 pandemic, the second and the third one during the pandemic. The change in antibiotic susceptibility in Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus strains isolated from urine, blood, and lower respiratory tract samples of patients hospitalized in intensive care units and wards of hospitals before (November 2019) and during the COVID-19 pandemic (November 2020 and July 2021) was investigated in this study. A total of 17 voluntary hospitals, members of the Antibiotic Sus- ceptibility Surveillance Study Group (ADSI) of the Society for Clinical Microbiology Specialists (KLIMUD), participated in the study. Identification of bacteria was performed with automated bacterial identification systems (VITEK2, bioMerieux, France or Phoenix, BD, USA). Antibiotic susceptibility tests were performed in one center with the Kirby-Bauer disc diffusion method and in other centers with automated antibi- otic susceptibility test systems (VITEK2, bioMerieux, France or Phoenix, BD, USA), and the results were evaluated according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. Antibiotic susceptibility ratios were statistically analyzed using either the chi-square or Fisher's exact test. A p-value of < 0.05 was considered statistically significant. Antibiotic susceptibility test results of a total of 4030 strains; 1152, 1139, and 1739 belonging to November 2019, November 2020, and July 2021, respectively; were examined. While cefotaxime and ceftazidime susceptibility rates in E.coli strains increased during the pandemic period compared to previous period (p= 0.04, p= 0.001, respectively); nitrofurantoin sensitivity (p= 0.02) and extended-spectrum beta-lactamase (ESBL) ratios (p< 0.001) were found to be decreased. It was determined that the susceptibility rates of all other examined antimicrobials did not change statistically. It was observed that the susceptibility rates of all antibiotics in K.pneumoniae isolates decreased during the pandemic period, but the ESBL rates increased between 2019-2020 (p= 0.01) and decreased between 2020-2021 (p= 0.02). It was found that ESBL rates increased before and after the pandemic. It was observed that the susceptibility to ciprofloxacin (p= 0.0001), levofloxacin (p= 0.003), and gentamicin (p= 0.005) in S.aureus strains increased during the pandemic period. No significant changes were observed in other antibiotic susceptibility rates. Methicillin resistance of S.aureus (MRSA) strains decreased between 2019-2020 (p= 0.03) and increased again in 2021 (p= 0.04) and returned to the pre-pandemic rate. Our study results suggest that the measures taken to reduce the spread of COVID-19 with the pandemic (such as quarantine practices, increased hand hygiene, mask use, and national/international travel restriction) may reduce the spread of bacteria such as ESBL-producing E.coli and the rate of MRSA, which is considered as a hand hygiene indicator. The increase in the later stages of the pandemic recalls the relaxation in compliance with hand hygiene rules. The decrease in the susceptibility rate of K.pneumoniae isolates to antibiotics and the increase in the ESBL rate may be due to inappropriate and excessive use of antibiotics during the pandemic period. However, we believe that these data should be supported by studies to be conducted nowadays when all the rules and measures are back as if the pandemic has ended.
- Open Access
- 12 December 2022
- Published by Taylor & Francis in Annals of Medicine
- Vol. 55 (1) , 266-275
Serotype distribution of Streptococcus pneumoniae and pneumococcal vaccine coverage in adults in Turkey between 2015 and 2018
To evaluate the serotype distribution and antibiotic resistance in pneumococcal infections in adults and to provide a perspective regarding serotype coverage of both current and future pneumococcal...
- 12 December 2022
- Published by Taylor & Francis in Annals of Medicine
- Vol. 55 (1) , 266-275
Open AccessSerotype distribution of Streptococcus pneumoniae and pneumococcal vaccine coverage in adults in Turkey between 2015 and 2018
To evaluate the serotype distribution and antibiotic resistance in pneumococcal infections in adults and to provide a perspective regarding serotype coverage of both current and future pneumococcal...
- 31 May 2021
- Published by Marmara University in Marmara Medical Journal
- Vol. 34 (2) , 127-131
Determination of fosfomycin susceptibility in carbapenemaseproducing K. pneumoniae strains isolated prior to clinical use of the intravenous formulation in Turkey
Objectives: The incidence of infections caused by carbapenem-resistant Enterobacteriaceae has increased worldwide. Limitations in the development of new antimicrobial agents have led clinicians to reconsider the clinical efficiency of old antibiotics, such as intravenous formulation of fosfomycin, in the treatment of multidrug-resistant Gram-negative bacterial infections. We investigated the fosfomycin susceptibility of carbapenemase-producing Klebsiella pneumoniae strains isolated prior to the clinical use of the intravenous formulation of fosfomycin in Turkey. Materials and Methods: A total of the 155 K. pneumoniae isolates which previously characterized at the molecular level for their carbapenemase were included in this study. The minimum inhibitory concentration of fosfomycin was determined by the agar dilution method. Results: Overall, 65.1% of the isolates were susceptible to fosfomycin. The MIC50 and MIC90 values were 32 and 256 mg/L, respectively. According to our results, at least two-third of carbapenemase-positive K. pneumoniae are susceptible to fosfomycin. Conclusions: Although, the susceptibility of fosfomycin, which has just been put into the clinical use of intravenous formulation in Turkey, is not very high, it can be considered as an alternative
- 31 May 2021
- Published by Marmara University in Marmara Medical Journal
- Vol. 34 (2) , 127-131
Determination of fosfomycin susceptibility in carbapenemaseproducing K. pneumoniae strains isolated prior to clinical use of the intravenous formulation in Turkey
Objectives: The incidence of infections caused by carbapenem-resistant Enterobacteriaceae has increased worldwide. Limitations in the development of new antimicrobial agents have led clinicians to reconsider the clinical efficiency of old antibiotics, such as intravenous formulation of fosfomycin, in the treatment of multidrug-resistant Gram-negative bacterial infections. We investigated the fosfomycin susceptibility of carbapenemase-producing Klebsiella pneumoniae strains isolated prior to the clinical use of the intravenous formulation of fosfomycin in Turkey. Materials and Methods: A total of the 155 K. pneumoniae isolates which previously characterized at the molecular level for their carbapenemase were included in this study. The minimum inhibitory concentration of fosfomycin was determined by the agar dilution method. Results: Overall, 65.1% of the isolates were susceptible to fosfomycin. The MIC50 and MIC90 values were 32 and 256 mg/L, respectively. According to our results, at least two-third of carbapenemase-positive K. pneumoniae are susceptible to fosfomycin. Conclusions: Although, the susceptibility of fosfomycin, which has just been put into the clinical use of intravenous formulation in Turkey, is not very high, it can be considered as an alternative
- 1 April 2021
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 15 (1) , 7-11
The Contribution of Syndromic Diagnostic Tests to Pertussis Epidemiology
- 1 April 2021
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 15 (1) , 7-11
The Contribution of Syndromic Diagnostic Tests to Pertussis Epidemiology
- 1 April 2021
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 15 (1) , 7-11
Sendromik Tanı Testlerinin Boğmaca Epidemiyolojisine Katkısı
- 1 April 2021
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 15 (1) , 7-11
Sendromik Tanı Testlerinin Boğmaca Epidemiyolojisine Katkısı
- 1 February 2021
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 27 (2) , 226-231
Evaluation of phenotypic tests for detection of carbapenemases: New modifications with new interpretation
- 1 February 2021
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 27 (2) , 226-231
Evaluation of phenotypic tests for detection of carbapenemases: New modifications with new interpretation